Psychopharmacology Interventions

77 Posts Found

Long-acting Injectable (LAI) Antipsychotics Use for Older Adults

July 16, 2020

Dose Conversions

July 8, 2020

Offering a long-acting injectable (LAI) for first-episode patients

June 19, 2020

Clozapine and Urinary Side Effects

May 29, 2020

Changing or switching a patient from a different long-acting injectable medication (LAI) to Invega Sustenna (paliperidone palmitate)

May 4, 2020

Changing or switching a patient from a different long-acting injectable (LAI) antipsychotic medication to Aristada

April 22, 2020

Diminished Efficacy of an LAI Medication

March 16, 2020

Shared Decision Making

March 16, 2020

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness

March 13, 2020

Clinical Indications

March 6, 2020

Oral Antipsychotics and LAIs

March 6, 2020

Transitioning a patient from risperidone oral to paliperidone palmitate (Invega Sustenna)

March 6, 2020

Deltoid Injection Side Effect Relief

March 6, 2020

Changing or switching a patient from a different long acting injectable medication (LAI) to Abilify Maintena

February 25, 2020

Pharmacological similarities and differences between paliperidone (Invega) and risperidone (Risperdal)

February 10, 2020

Long-acting Injectable (LAI) Antipsychotics are Available in the U.S.

February 7, 2020

Invega Trinza (paliperidone palmitate 12-week LAI)

January 27, 2020

Fluphenazine Decanoate (“Prolixin Dec”)

January 27, 2020

Haloperidol Decanoate (“Haldol Dec”)

January 23, 2020

Aristada (aripiprazole lauroxil LAI)

January 23, 2020